Camaisa Allan

Track

Insider profile

Performance

Overall performance
3.9
Performance over holding periods
3.9
30 days 90 days 120 days
Average return 43% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Camaisa Allan's trades of Calidi Biotherapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-16 2025-12-12
S Sale
792 +16.5%
416.72
US$4,816,777 		792 +16.5% 416.72 US$4,816,777
2024-12-18 2024-12-17
S Sale
81,001 +45.4%
425.44
US$1,880,478 		81,001 +45.4% 425.44 US$1,880,478